The QualityStocks Daily Thursday, July 26th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (CYTXW) +100.00%

CNBC Breaking News (SVU) +65.40%

MarketClub Analysis (BPI) +52.90%

The QualityStocks Daily Stock List

PEN, Inc. (PENC)

DreamTeamNetwork, SmallCapVoice, and Outcast Traders reported previously on PEN, Inc. (PENC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PEN, Inc. is a global leader in developing, commercializing, and marketing enhanced-performance products enabled by nanotechnology. PEN stands for Products Enabled by Nanotechnology.  Products from its family of companies are for healthcare to homecare, homeland defense to food security, and transportation to recreation. PEN is headquartered in Miami, Florida.

PEN’s Applied Nanotech, Inc. subsidiary is in Austin, Texas. It functions as the Design Center conducting contract services for government and private customers and new product development for PEN focusing on unique and advanced product solutions in the areas of safety, health, and sustainability.

PEN is the combination of Nanofilm, Ltd. and Applied Nanotech Holdings, Inc. These are two nanotechnology innovators. PEN established to channel the potential of nanotechnology in real-world products for real-world users. With the combination of these two companies, PEN provides nano-layer coatings, nano-based cleaners, and nano-composite products.

PEN, by way of its wholly-owned subsidiary PEN Brands LLC (previously Nanofilm Ltd.), develops, manufactures, and sells products based on nanotechnology. This includes its Ultra Clarity® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products, CLARITY ULTRASEAL® nanocoating products for glass and ceramics, and an environmentally friendly surface protector, fortifier, and cleaner.

This week, PEN reported financial results for Q2 ended June 30, 2017. For the three months ended June 30, 2017, total Revenues were $2,002,609, versus revenues of $2,209,828 in the comparable period in 2016. For Q2 of 2017, overall Gross Profit amounted to $656,257, versus $793,086 for Q2 of 2016. Gross margin was 33 percent, versus 36 percent in the prior year period. Operating Loss was $363,570 in Q2 of 2017, versus an operating loss of $219,024 in Q2 of 2016.

PEN generated a loss for the quarter, mainly because of expenses associated with the upcoming relocation of its Product segment operations. However, the Company generated positive cash flow from operations during the quarter.

Mr. Scott Rickert, PEN's President, Chairman and Chief Executive Officer, said: "The second quarter was an active one at PEN. We commenced the relocation of our Ohio operations to a smaller facility nearby, a move that will allow us to outsource a good portion of our manufacturing and lower our cost structure while providing the flexibility to quickly meet the diverse and dynamic packaging needs of our customers. More importantly, it will allow PEN to focus on our primary mission of building a consumer products company offering compelling products enabled by nanotechnology. We are preparing for upcoming relaunch of our key health and safety products, including our environmentally friendly surface protector, which we expect to kick off in the fourth quarter once the relocation is complete.”

PEN, Inc. (PENC), closed Thursday's trading session at $0.7602, up 5.19%, on 229 volume with 2 trades. The average volume for the last 60 days is 581 and the stock's 52-week low/high is $0.7002/$1.8001.

chart

Omnitek Engineering Corp. (OMTK)

OTCPicks, Marketbeat.com, FeedBlitz, and Penny Stock Rumble reported earlier on Omnitek Engineering Corp. (OMTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that utilize the Company’s technology. These provide its international customers with unique alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering has its head office in Vista, California.

The Company’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. The strategic alliance provides an assembly-line remanufacturing process providing the benefits of capacity, consistency, as well as quality. Omnitek Engineering’s commitment is to be at the frontier of technology. In addition, its commitment is to develop pioneering solutions that redefine the future of low emissions, energy independence, and transportation.

Omnitek’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.

The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, first for the extensively-used Mercedes OM904 and OM906 engines. LKQ is a top provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering announced in July of 2016 that it received global certification for its patented fuel rail technology. This is founded on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek Engineering will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology.  Olson-Ecologic Engine Testing Laboratories will serve as project manager. Olson-Ecologic will be responsible for rigorous testing at its facility before demonstrations under real-life conditions.

This month, Omnitek Engineering reported results for its Q2 and six months ended June 30, 2017. The results reflect a significantly reduced Net Loss for both periods, an improved cash position, as well as the start of an earlier announced grant program to develop an 18-liter off-road natural gas engine.

Net Revenues for Q2 were $246,314 versus $252,316 the year prior. For the same period, Omnitek reported a Net Loss of $191,589, or $0.01 per share, versus a Net Loss of $292,939, or $0.01 per share, the year prior.

Net Revenues for the six-month period were $537,968 versus $591,899 the year prior. For the same period, it reported a Net Loss of $400,630, or $0.02 per share, versus a Net Loss of $489,683, or $0.02 per share, the year prior.

Omnitek Engineering Corp. (OMTK), closed Thursday's trading session at $0.352, even for the day, on 19,625 volume with 7 trades. The average volume for the last 60 days is 48,658 and the stock's 52-week low/high is $0.0551/$0.47.

chart

Arch Therapeutics, Inc. (ARTH)

Jet-Life Penny Stocks, Stock Shock and Awe, Promotion Stock Secrets, Stock Gumshoe, Equity Observer, PCG Advisory, Stock Beast, Value Penny Stocks, PennyPro, Wall Street Mover, Penny Stock General, Shiznit Stocks, Stock Commander, Fast Money Alerts, HotStockProfits, and Wall Street Resources reported earlier on Arch Therapeutics, Inc. (ARTH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

A medical device company, Arch Therapeutics, Inc. is a developer of novel liquid, gel and solid hemostatic and wound care devices. It is developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Its goal is to develop and commercialize products based on its pioneering technology platform. This platform makes surgery and interventional care faster and safer for patients. The underlying technology, exclusively licensed from a leading university, supports an inventive platform of smart materials that fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics is based in Framingham, Massachusetts.

Arch’s flagship development stage product candidate is called AC5™ (AC5 Surgical Hemostatic Device™). This is a synthetic peptide consisting of naturally occurring amino acids. AC5™ is undergoing design to smoothly attain hemostasis in minimally invasive (laparoscopic) and open surgical procedures. The Company’s solution smartly controls the movement of fluids and substances. AC5™ stops bleeding quickly. AC5™ conforms to irregular wound geometry and helps in maintaining a clear field of vision directly into the wound area.

AC5™, when squirted or sprayed onto a wound, quickly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) irrespective of type of surgery or, based on early data, clotting ability, and healing occurs normally. Arch indicates that in preclinical tests, AC5™ has been simple, effective, and versatile.

Arch Therapeutics’ preclinical pipeline includes a number of product applications with high medical need. This includes care of chronic cutaneous wounds and burns, prevention of surgical adhesions, sealing gastrointestinal anastomoses and ophthalmology. Preclinical research is continuing with different partners. This approach has the advantage of managing costs and engaging relevant experts. Arch expects to advance the best product candidates further along the development cycle.

Last month, Arch Therapeutics announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) on July 17, 2017 for its AC5™ Topical Gel. If its 510(k) application is cleared by the FDA, the expectation is that the AC5™ Topical Gel will be used for external wounds.

Mr. Terrence W. Norchi, Arch Therapeutics’ President and Chief Executive Officer, said, "This is an important milestone for Arch. As previously shared, we planned to request 510(k) clearance in the middle of 2017 for the external use AC5™, which is a significant acceleration from original expectations of seeking U.S. regulatory approval through the PMA process, and we have met that goal. This achievement illustrates the ability of our team to execute on our development and regulatory strategies."

Arch Therapeutics, Inc. (ARTH), closed Thursday's trading session at $0.4351, up 1.19%, on 43,436 volume with 22 trades. The average volume for the last 60 days is 292,865 and the stock's 52-week low/high is $0.25/$0.89.

chart

mCig, Inc. (MCIG)

Shiznit Stocks, Stockgoodies, CFN Media Group, The Street, GrowthPennyStocks, Penny Stock General, MadMoneyPicks, MassiveStockProfits, Wall Street Equities Research, Promotion Stock Secrets, TopPennyStockMovers, Stock Shock and Awe, PennyPro, Fast Money Alerts, Cannabis Financial Network News, and SmallCapVoice reported previously on mCig, Inc. (MCIG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

mCig, Inc. is a diversified business serving the legal cannabis, hemp, and CBD markets by way of its lifestyle brands. The Company is a distributor of innovative cannabis

related products. mCig has transitioned from a vaporizer manufacturer to an industry leading, large scale, full-service cannabis cultivation construction enterprise. Its Scalable Solutions division presently operates in the fast-expanding Nevada market. The Company’s devotion is to be the foremost distributor of technology, products, and services to the industry.  mCig has its corporate office in Henderson, Nevada.

mCig owns the Rollie and Vapolution brands. The Company has its Grow Contractors division that provides services to growers of every level in the developing cannabis industry. This division provides turnkey, durable, completely modular, ISO clean, high-yielding cultivation rooms. This permits growers to create a first-rate growing environment all year.

Regarding Commercial Scale, Grow Contractors utilizes Structurally Insulated Panels to create a hermetically sealed, mold/pest free, and sterile environment. Its panels provide high R-Value thermal resistance, significantly lessening a customer’s energy consumption.

Concerning Grow Greenhouse, Grow Contractors’ Greenhouse Hybrids integrate the efficiency of structurally insulated panels with natural sunlight. It provides flexible multi-tier growing layouts, rollup security/blackout panels, and environmental control.

Furthermore, mCig has partnered with industry leaders and designers to provide a drop and grow solution for the home grower. The Home Grow Rooms are professionally designed, climate controlled rooms. They are suited for beginners and experts.

mCig also offers Consulting Services. This is to help clients navigate state, county, and city regulations for compliancy. Its Consulting Services provide the expertise for this. Additionally, mCig has entered the technology space to satisfy its developing role in technology and in keeping its increasing following informed. mCig also focuses on providing distribution, media and events, and business services within the cannabis industry.

At the beginning of August, mCig announced the extension of its offerings to include merchant processing. The Company has created a new entity, partnering with a merchant provider with more than 10 years of experience, allowing mCig to provide a wide-ranging, seamless, and secure payment solution via a trusted source. After rigorous testing, mCig can provide merchant processing exclusively to cannabis businesses and dispensaries. Its merchant service provides a simple, direct, United States-based solution that can accept credit cards online and at participating dispensaries.

Also, this month, mCig announced a partnership between its Job Search Portal (420JobSearch.com) and ZipRecruiter.com. 420jobsearch.com recently entered into an agreement with ziprecruiter.com to allow both companies to widen the scope of jobs available to job seekers. mCig's 420JobSearch is considered one of the largest job and recruitment sites in the cannabis industry. It has leading job boards for employers, job seekers, as well as recruiters.

Today, mCig announced that it filed with the U.S. Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the year ended April 30, 2017. The Company recorded a record-breaking year. It saw considerable growth in its Revenue, Net Earnings, Cash position, and Balance Sheet. Selected highlights include Revenue from continuing operations for Fiscal Year (FY) 2017 of $4,777,072 versus $1,723,421 from the prior year. This represents an increase of $3,053,651 or roughly 277 percent.

Gross Profit for FY 2017 was $1,896,029 versus $290,773 from the prior year. mCig’s Net Operating Income rose by $2,337,944 to $929,989 for FY 2017 from a Net Loss of ($1,408,955) for the prior year. The Company recorded a $1,527,352 Net Profit, $1,539,233 EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization), and a $32,685 Adjusted Net Income.

mCig, Inc. (MCIG), closed Thursday's trading session at $0.25, up 1.63%, on 862,491 volume with 263 trades. The average volume for the last 60 days is 2,018,491 and the stock's 52-week low/high is $0.125/$0.427.

chart

Q BioMed, Inc. (QBIO)

Stock News Now, StockPicksNYC, and SeeThruEquityResearch reported on Q BioMed, Inc. (QBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biomedical acceleration and development company listed on the OTCQB. Its commitment is to licensing and acquiring biomedical assets across the healthcare spectrum. The Company previously went by the name ISMO Tech Solutions, Inc. It changed its name to Q BioMed, Inc. in July 2015. Q BioMed has its corporate office in New York, New York.

The Company’s dedication is to provide these target assets the strategic resources, developmental support, and expansion capital they need to ensure they meet their developmental potential, enabling them to provide products to patients in need. Q BioMed’s mission is to license and acquire innovative life sciences assets from academia or small private companies.

The Company is focusing on clinical stage and unique products where the technical, regulatory, and commercial risks have been reduced or significant valuation modulations are pending. Q BioMed has manifold assets across a wide spectrum of healthcare related products, companies, and sectors. These assets will undergo development to provide returns through organic growth or out-licensing, sale, or be spun out into new public companies.

Q BioMed has started production of Strontium-89 Chloride - a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain. AB-Rated Strontium Chloride Sr89 Injection USP (Sr89) can be used in combination with, or to lessen the need for opiate based drugs, as well as in combination with cancer therapeutic drugs.

In addition, Q BioMed is developing an innovative molecule delivered in an easy-to-administer eye drop designed to repair the normal flow of fluid in the eye resulting in the decreasing of IOP (Intraocular Pressure) - one of the main causes of glaucoma. This platform is innovative and first-in-class. Q BioMed, together with its partner, Mannin Research, Inc, is the only company targeting this mechanism of action.

Together with Mannin Research, Q BioMed has made major progress on their Tie2 activating molecule. At present, it is undergoing optimization for a topical eye drop for the treatment of open angle glaucoma. Recently, they filed patents with the United States Patent and Trademark Office (USPTO) disclosing novel compounds capable of activating Tie2 receptor-mediated signaling. Moreover, they have completed initial proof-of-concept work on a novel biologic targeting Tie2 (MAN-11).

Yesterday, Q BioMed announced that it is extending its option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q BioMed will continue to assess the feasibility and usability of GDF15 as a companion diagnostic to the MAN-01 small molecule now undergoing optimization for the topical treatment of glaucoma. GDF 15 is a novel biomarker for monitoring glaucoma.

Q BioMed, Inc. (QBIO), closed Thursday's trading session at $2.12, down 1.85%, on 46,606 volume with 93 trades. The average volume for the last 60 days is 99,860 and the stock's 52-week low/high is $2.00/$5.90.

chart

Digerati Technologies, Inc. (DTGI)

OTCPicks, AllPennyStocks, MicrocapVoice, and SmallCapVoice reported previously on Digerati Technologies, Inc. (DTGI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Digerati Technologies, Inc. is a diversified holding company whose shares trade on the OTC Markets’ OTCQB. It has subsidiary operations in the cloud communications industry. The Company, via its wholly-owned subsidiary, Shift8 Technologies, Inc., provides Internet-based telephony products and services through its cloud telephony application platform and session-based communication network. Digerati Technologies is headquartered in San Antonio, Texas.

Digerati’s Shift8 Networks subsidiary is an enterprise hosted PBX and cloud-based Unified Communications service provider. Shift8 Networks provides voice, video, and mobile communications to thousands of businesses by way of its Channel Alliance program.

Shift8 integrates hosted VoIP with cloud-based messaging and desktop applications. Shift8's VAR program targets PBX Vendors, Information Technology (IT) Services firms, Managed Service Providers, and Systems Integrators that lack a cloud telephony infrastructure, but have an embedded customer base that necessitates Internet-based telephony services.

Fundamentally, Digerati Technologies is an established and award-winning provider of cloud communication services. It serves traditional carriers, telephony resellers, and other VoIP (Voice over Internet Protocol) carriers in the United States and abroad. The Company provides VoIP communication services to telecommunications enterprises.

Digerati also provides Internet-based services. These include fully hosted IP/PBX services, IP trunking; call center applications, prepaid services, and interactive voice response auto attendant. Furthermore, services include call recording, simultaneous calling, voicemail to email conversion, and numerous customized IP/PBX features in a hosted or cloud environment for specialized applications.

Digerati Technologies completed the acquisition of Synergy Telecom, Inc. last year Digerati’s Shift8 Networks is combining Synergy Telecom with its Texas-based business and operations. Synergy Telecom is a leading provider of cloud communication services in Texas.

Digerati Technologies will retain the “Synergy Telecom” brand for its Texas operations. Digerati began the transition from its Shif8 brand to the Synergy Telecom brand effective February 15, 2018 and the phase out of the Shift8 name by May 1, 2018. This includes a corporate name change for the Texas corporation.

Digerati Technologies completed the acquisition of T3 Communications, Inc. this year. It stated that this acquisition positions Digerati Technologies for hyper-growth in two of the fastest growing sectors of the telecommunications industry, UCaaS (Unified Communications as a Service) and SD-WAN (Software-Defined Wide-Area Network). T3 Communications is a top provider of cloud communications and broadband solutions in Southwest Florida.

T3 Communications has its corporate office in Fort Myers, Florida. T3 locally provides high-quality communication services in the southwest part of the State. T3 maintains innovative technology to support its solutions.

Mr. Arthur L. Smith, Digerati Technologies’ Chief Executive Officer, said in May, "The acquisition of T3 Communications has created a solid foundation for our continued roll-up of other profitable cloud communication providers that have excelled at that 'local touch' and displaced the national and incumbent providers who are not adequately serving the small-to-medium-sized-business.

Digerati Technologies, Inc. (DTGI), closed Thursday's trading session at $0.50, down 1.96%, on 5,377 volume with 6 trades. The average volume for the last 60 days is 5,091 and the stock's 52-week low/high is $0.205/$0.85.

chart

RedHawk Holdings Corp. (IDNG)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (IDNG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.  

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S.  RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

In early August, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (IDNG), closed Thursday's trading session at $0.0029, down 3.33%, on 1,682,432 volume with 13 trades. The average volume for the last 60 days is 617,884 and the stock's 52-week low/high is $0.0025/$0.021.

chart

Manhattan Scientifics, Inc. (MHTX)

SmallCapVoice, Xtremepicks, The Penny Play, FeedBlitz, Hawk Associates, StockHotTips, BullRally, OurHotStockPicks, AllPennyStocks, and HotStockChat reported earlier on Manhattan Scientifics, Inc. (MHTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Manhattan Scientifics, Inc. concentrates on the commercialization of disruptive technologies in the nano-medicine space. The OTCQB-listed Company is currently developing commercial medical prosthetics applications for its ultra-fine grain metals. Its goal is to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, (now Imagion Biosystems), its wholly-owned subsidiary. Manhattan Scientifics is based in New York, New York. The Company has an office in Albuquerque, New Mexico, and Montreal, Quebec.

Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)). Sandia National Laboratories is a multi-mission laboratory operated by National Technology and Engineering Solutions of Sandia LLC, a wholly-owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy’s National Nuclear Security Administration.

Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate, and validate an innovative technology developed by Mr. Edward R. Flynn, PhD, for the very early detection of cancer. The Company has delivered its pioneering cancer measurement instrument to MDACC.

Manhattan Scientifics focuses on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company creates Intellectual Property (IP) portfolios and business cases supporting new technologies. It guides them to relationships with industrial partners who are well-prepared to launch product.

The Company’s technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods. Currently, Manhattan Scientifics is centering on nanoparticle-based cancer detection via Senior Scientific. Moreover, it is focusing on nanostructured metals technology via wholly-owned subsidiary Metallicum, Inc.

Senior Scientific has formed a research collaboration with Weill Cornell Medicine. For this alliance, it will bring its magnetic relaxometry technology to Weill Cornell Medicine. Scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.

Manhattan Scientifics is also working on the start of product trials on its cancer detection product. The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier.

Manhattan Scientifics started as a technology incubator. Early in its history, the Company worked on acquiring a number of technologies in the fields of holographic data storage, water purification, alternative energy, advanced computer haptics and currently, nanotechnology. The Company’s chief source of latent commercial technologies are the U.S. government laboratories in New Mexico.

Manhattan Scientifics, Inc. (MHTX), closed Thursday's trading session at $0.01755, up 8.74%, on 70,750 volume with 4 trades. The average volume for the last 60 days is 175,310 and the stock's 52-week low/high is $0.011/$0.043.

chart

Saracen Mineral Holdings Limited (SCEXF)

Smart Stock Trading Strategies, YCharts, Stockhouse, GoldStockData, OTC Markets, The Subway Trader, 4-Traders, Stockscores, and Stock Market Watch reported on Saracen Mineral Holdings Limited (SCEXF), and we report on Company as well, here at the QualityStocks Daily Newsletter.

Saracen Mineral Holdings Limited engages in the gold mining business in Australia. The Company also explores for nickel deposits. Its production comes from two WA projects - Carosue Dam and its new Thunderbox mine. Both of these operations have long lives with extensive potential for further growth through exploration. Saracen Mineral Holdings is headquartered in Perth, Western Australia (WA).

Saracen’s vision is to join the Australian mid-tier gold producer ranks through doubling production to 300koz p.a. at an AISC (All-in Sustaining Costs) of less than A$1,075/oz, within the next two years.

Concerning its exploration, all of Saracen’s mines are open along strike and at depth. In addition, all mines are shallow with grades increasing at depth.

Saracen Mineral Holdings also has premier Reserve growth - a 40 percent increase to 2.1Moz at key assets next to processing centers. The Company’s Carosue Dam is surrounded by major miners Goldfields and AngloGold.

At Carosue Dam, an under-explored mine corridor presents opportunity for further repeat deposits. Production growth at Carosue Dam is through a potential mill expansion (to roughly 3Mtpa) and introduction of paste fill at the key underground mines to allow for close to full orebody extraction (improve mine recoveries and efficiencies).

Growth opportunities at the Thunderbox mine include Kailis high grade (2.5g/t open pit, soft ore); Thunderbox Stage 2 underground (518koz over 7 years); Bannockburn (roughly 200koz @ 1.5g/t); and also the Thunderbox D Zone (near surface northern cut-back).

Saracen Mineral Holdings has reported another strong quarter (JunQ) to deliver record FY18 production and surpass revised production guidance. The Company reported FY18 gold production of 316,453oz (guidance 310-315koz), with Carosue Dam (CDO) contributing 171.3koz and Thunderbox (TBO) providing 145.2koz.

Saracen is forecasting more production growth in FY19. The Company has upgraded Group guidance to 325-345koz (previously 300koz) at an AISC (All-in Sustaining Costs) of A$1,050-1,100/oz.

Average gold price received of A$1,655/oz provided revenues of approximately A$136M and implied approximately A$459/oz margin. Saracen Mineral Holdings remains debt free. However, the Company retains an undrawn corporate facility.

Saracen Mineral Holdings Limited (SCEXF), closed Thursday's trading session at $1.45, even for the day. The average volume for the last 60 days is 2,125 and the stock's 52-week low/high is $1.01/$1.76.

chart

International Stem Cell Corp. (ISCO)

Serious Traders, Tiny Gems, Tip.us, MissionIR, Marketbeat and StocksToBuyNow reported on International Stem Cell Corp. (ISCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company. It is developing stem cell-based therapies and biomedical products. The Company’s concentration is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. OTCQB-listed, International Stem Cell is based in Carlsbad, California. The Company has a research facility in Oceanside, California.

International Stem Cell’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). The above-mentioned hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™.

The UniStemCell™ bank is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens vital for transplantation.

International Stem Cell scientists have created the first parthenogenetic, homozygous stem cell line. The Company produces and markets specialized cells and growth media for therapeutic research globally via its subsidiary Lifeline Cell Technology and stem cell-based skin care products through its subsidiary Lifeline Skin Care.

International Stem Cell announced this past May that the United States Patent and Trademark Office (USPTO) granted the Company a key patent (US9926529B2) on the method used to manufacture ISC-hpNSC. These are the cells administered in the Company’s ongoing Parkinson’s disease clinical trial. They can potentially be used in therapies to treat traumatic brain injury and stroke.

In June, International Stem Cell announced that the first patient of the third cohort of the clinical trial for Parkinson's disease was successfully transplanted with 70,000,000 ISC-hpNSC®. The operation was performed at the Royal Melbourne Hospital (RMH) in Melbourne, Australia by a team of RMH neurosurgeons. The surgery proceeded with no complications. The patient was discharged soon after.

This month, International Stem Cell announced that its wholly owned subsidiary, Lifeline Cell Technology (LCT), expanded its business and manufacturing capabilities to fulfill present and forecasted demand. The upgrades were made in all operational departments, including new equipment that has considerably improved its manufacturing and testing capabilities, now handling quadruple its original batch sizes.

In addition, LCT hired more staff in manufacturing. LCT is in the process of expanding its facilities to include a formulation lab, a warehouse, and more working space.

International Stem Cell Corp. (ISCO), closed Thursday's trading session at $1.5325, up 0.82%, on 1,387 volume with 7 trades. The average volume for the last 60 days is 8,998 and the stock's 52-week low/high is $1.08/$2.05.

chart

Teranga Gold Corporation (TGCDF)

The Street, Stockhouse, OTC Markets, 4-Traders, StreetInsider, InvestorsHub, The Northern Miner, Capital Equity Review, Simply Wall St, and 24hgold reported on Teranga Gold Corporation (TGCDF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Teranga Gold Corporation is a multi-jurisdictional West African gold company. Its focus is on production and development and the exploration of greater than 6,400 km2 of land situated on prospective gold belts. Teranga is advancing its Wahgnion Gold Project, with a recently released positive feasibility study (FS), and conducting wide-ranging exploration programs in Burkina Faso, Senegal and Côte d’Ivoire. Listed on the OTCQX, Teranga Gold is based in Toronto, Ontario.

Teranga has close to 4.0 million ounces of gold reserves from its combined Sabodala Gold operations and Wahgnion Gold Project. Since its initial public offering (IPO) in 2010, the Company has produced more than 1.4 million ounces of gold from its operations in Senegal, which as of June 30, 2017 had a reserve base of 2.7 million ounces of gold.

The Sabodala Gold mine is the only gold mine and mill in Senegal, West Africa.  It is about 650 km southeast of Dakar, the capital of Senegal. Sabodala has been in operation since 2009.

Teranga owns and operates the Sabodala Gold mine. The Sabodala Mining Concession and the surrounding exploration permits are positioned within the highly prospective Kedougou-Kenieba Inlier, which forms part of the Paleoproterozoic age Birimian Terrane of the West African Craton.

The Banfora Gold Project was acquired in October 2016 as part of the Company’s acquisition of Gryphon Minerals. The fully permitted, high-grade, open pit Banfora Gold Project is in the south-west of Burkina Faso, West Africa in a major gold producing district host to several world class gold deposits. Teranga Gold owns 90 percent of the Project. The Burkina Faso government owns the remaining 10 percent.

This month, Teranga Gold announced that its most recent diamond drill program on the Golden Hill property in Burkina Faso, West Africa returned near surface and deeper gold intersections, which will enhance resources at several advanced prospects.

Furthermore, the recent drilling evaluation program identified a new near-surface discovery at Peksou North, one of 9 prospects drilled at Golden Hill over the past 18 months. Teranga Gold is investing $8 million in project drill programs this year.

Teranga Gold will release its Q2 2018 financial and operating results on Thursday, August 2, 2018 at approximately 6:00 a.m. ET.  A conference call and webcast hosted by Company Management will follow at 8:30 a.m.

Teranga Gold Corporation (TGCDF), closed Thursday's trading session at $3.23, down 1.82%, on 140 volume with 2 trades. The average volume for the last 60 days is 17,977 and the stock's 52-week low/high is $1.83/$6.40.

chart

Drone Delivery Canada Corp. (TAKOF)

The Wall Street Analyzer, Stockhouse, 4-Traders, WalletInvestor, OTC Markets, Stock News Now, Penny Stock Hub, Stockwatch, and Barchart reported on Drone Delivery Canada Corp. (TAKOF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Drone Delivery Canada Corp. is a drone technology business. The Company’s emphasis is on the design, development, and implementation of its proprietary logistics software platform, using drones. Its platform will be used as Software as a Service (SaaS) for government and corporate organizations. Drone Delivery Canada is based in Vaughan, Ontario and the Company lists on the OTC Markets Group’s OTCQB.

Drone Delivery Canada looks to receive revenue from Integration Fees, Set Up Fees and Drone Delivery Flights based upon a take or pay model across the nation. At present, its Sparrow Drone, its proprietary software FLYTE, and the Company are considered compliant by the Canadian regulator, Transport Canada, within Canadian airspace.

Drone Delivery Canada also has its Raven drone. The expectation is that this and other drones will complement the Company’s Sparrow drone with more payloads and distance capabilities.

The expectation is that the Raven will have a payload capacity of 20 lbs. and a distance of greater than 20 km. In December of 2017, the aforementioned Sparrow attained its Declaration of Compliance accepted by Transport Canada.

Drone Delivery Canada has commenced development of its newest cargo delivery drone, 'The Condor', with a lifting capability estimated at 400 pounds of payload. The Condor cargo delivery drone is being engineered to provide payload capacities of up to 400 lbs and designed to fly approximately 150 km. 

The Condor features a significantly larger payload compartment in comparison to the Raven and Sparrow. The Condor looks to accept pallet size payload shipments. The Condor will be completely integrated with the proprietary Drone Delivery Canada FLYTE™ management system.

Through its newly-created American subsidiary, Drone Delivery USA, Drone Delivery Canada looks to export its technology to the United States to enable its larger American clients to harness and deploy the Company’s Drone technology in U.S. airspace.

Recently, Drone Delivery Canada announced that Transport Canada chose the Company to participate in the department's Beyond Visual Line-of-Sight Pilot Project. The Pilot Project will advance its Beyond Visual Line-of-Sight (BVLOS) capabilities in Canada. The Project will also further Drone Delivery Canada's capabilities in the Moosonee and Moose Cree First Nation communities in Northern Ontario this summer.

Drone Delivery Canada Corp. (TAKOF), closed Thursday's trading session at $1.1668, down 2.77%, on 47,725 volume with 25 trades. The average volume for the last 60 days is 4,452 and the stock's 52-week low/high is $0.30/$1.8198.

chart

All for One Media Corp. (AFOM)

OTC Markets, Street Register, MarketWatch, InvestorsHub, and Barchart reported on All for One Media Corp. (AFOM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

All for One Media Corp. is a tween marketing company listed on the OTCQB. The estimation is that the tween demographic is responsible for no less than $260 billion yearly in direct sales in the U.S. alone. Called “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All for One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. All for One Media has its corporate office in Mount Kisco, New York.

At present, the Company is producing "Crazy For the Boys." All for One Media, through entertainment, is working to deliver a message, which will resonate with kids to impact the epidemic of bullying and cyber-bullying. Also, the Company is working to help individuals who have been affected by bullying to deal with it in a positive and constructive way.

“Crazy For The Boys” is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. The film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs concerning peer pressure, unrequited love, and teen angst.

The expectation is that “Crazy For The Boys” will generate revenues from a number of sources. These include domestic and global distribution, video on demand (VOD), merchandising, soundtrack, live performances, and other ancillary sources.

All for One Media has initiated the recording of the sixteen songs that will be included in "Crazy for the Boys", as well as included on the Soundtrack for the movie. Several songs will be produced by multi-platinum Producer Jeff Coplan. Recording began on May 2, 2017 at legendary studio "The Jungle Room" in Glendale, California.

In May of this year, All for One Media announced that it received a commitment letter from its production partner Sunset Pictures. This is for domestic distribution for the motion picture Crazy for the Boys through its output deal with 20th Century Fox, inclusive of theatrical release via Atlas Distribution, and all ancillary rights including Netflix, Cable, and Network TV, and DVD, Blue ray, VOD, Digital, and more. Sunset Pictures will facilitate Print and Ad Funds to boost the marketing of the theatrical release and the marketing of the film.

Recently, All for One Media, by way of its wholly-owned subsidiary, Crazy for the Boys movie, LLC, announced the casting of former "Saturday Night Live" star, Cheri Oteri in its upcoming feature film as the Principal of JFK High School. The upcoming musical dramedy began shooting on July 5, 2017 in Savannah, Georgia. Cheri Oteri is famous for being one of the cast members on Saturday Night Live from 1995 to 2000. Crazy for the Boys is being marketed as a modern day "Grease." Crazy for the Boys is targeting a Spring Break 2018 theatrical release.

All for One Media Corp. (AFOM), closed Thursday's trading session at $0.0476, up 4.62%, on 123,583 volume with 9 trades. The average volume for the last 60 days is 264,625 and the stock's 52-week low/high is $0.013/$0.225.

chart

The QualityStocks Company Corner

Auscrete Corp. (OTC: ASCK)

The QualityStocks Daily Newsletter would like to spotlight Auscrete Corp. (ASCK).

Auscrete Corp. (OTC: ASCK), a building products manufacturer of environmentally friendly, energy efficient housing and commercial structures using their proprietary technology, announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology. Auscrete’s unique process produces a medium that is cost-efficient, extremely soundproof, offers high insulation values, requires very low maintenance, won’t burn, non-toxic, highly resistant to insects and mold, and resists damage from hurricane forces and earth tremors. It’s a more affordable, energy-efficient “green” construction material that can be utilized for building residential housing and commercial structures.

Affordable homes are increasingly becoming more difficult to purchase in the U.S. with the median price of a new home consistently rising while wages stay stagnant in many areas and mortgage rates rise. The average price of new homes sold in the U.S. in 2017 was nearly $385,000, according to Statista. The homeownership rate in the U.S. has been in decline since 2004, the report states, and now amounts to a little more than 64 percent of Americans.

Auscrete’s lightweight concrete product is described as an aerated concrete material following infusion of a specially designed foaming agent during manufacture. This technology enables the product to have millions of minuscule air bubble “aggregates” introduced and evenly distributed throughout the cast sections, which creates a unique, lightweight product without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation amalgamation that guarantees greater comfort in a wide range of climatic conditions and a reduction in heating and cooling costs. The final product is a light and strong concrete panel with an extremely high insulation value, as well as excellent fire resistance and sound-proofing qualities.

Auscrete’s product also offers a high strength-to-weight ratio, allowing architects and engineers to develop new design and construction concepts that take advantage of the product’s reduced weight, which is nearly half that of normal concrete. Each panel can be cast in large sections, a common size being 16-feet by 8-feet, for easier transportation and faster construction on site. Savings are enhanced, not only by the energy efficiency of each panel, but through the use of mass production techniques. Auscrete estimates the company can produce a ready-to-move-in turnkey house for around $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot in the U.S., according to a report by Zillow.

Auscrete is constructing its flagship, 10-acre facility in Goldendale, Washington, on initially 5 acres the company recently purchased with the option to purchase another 5 adjacent acres. This new campus will ultimately comprise of 6 buildings, including 3 production buildings of 25,000 sq. ft. with each production buildings’ capacity of 100 homes annually, giving this flagship facility the ability to produce 300 homes or equivalent commercial structures per year.

During this construction phase, Auscrete has leased a commercial building in Goldendale. The facility will be used as a temporary headquarters and will also serve as a refurbishing station for production equipment the company has developed and used in its prior production plant. John Sprovieri, CEO and founder of Auscrete Corporation, is at the helm of the company with Mike Young serving as vice president of internal operations and Otto Paulette controlling the in-house mechanical services.

Auscrete’s Investor Relations Director, Lee Odom said, “The company’s construction process has already attracted interest from many developers, contractors and builders, some with large tracts of land looking to make available, significant numbers of Affordable Homes throughout the Country. Additionally, there have been significant commercial projects offered including 300 room destination hotel resorts, correctional facilities, a shopping complex, and a court house along with a flood of inquiries from people who are looking for more affordable building options”.

“This could really launch the commercial aspect for?ASCK, apart from residential home production which so many investors are not yet aware of,” Odom said. “A strong combination of both will lead?ASCK?to better performance through all business cycles, thus continuing to enhance the shareholder values, which is always the ultimate goal of Auscrete Corporation.”

Auscrete Corp. (ASCK), closed the day's trading session at $0.07, up 7.53%, on 77,712 volume with 12 trades. The average volume for the last 60 days is 123,237,769 and the stock's 52-week low/high is $0.0001/$0.10.

Recent News

chart

Zenergy Brands, Inc. (OTC: ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (Ticker:  ZNGY), the nation's leading next-generation utility, announced today that it has closed a Zero Cost contract with a Texas-based franchisee of a well-known fast food restaurant chain, in a deal worth an aggregate contract value of $393,969.60.

Zenergy Brands, Inc. (OTC: ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0009, up 12.50%, on 277,776,557 volume with 567 trades. The average volume for the last 60 days is 14,694,022 and the stock's 52-week low/high is $0.0008/$0.03.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

Blockstrain Technologies Corp. (OTC:BKKSF) (TSX-V:DNAX) highlighted in article on the United States shipping and logistics industry which accounts for nearly $1.5 trillion each year. With networks of producers, shippers, and consumers coordinating to access products, inefficiencies are an inevitable industry reality.

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.19, up 8.57%, on 473,880. The stock's 52-week low/high is $0.105/$1.20.

Recent News

chart

Pressure BioSciences Inc. (OTCQB: PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Imagine food, such as milk, that doesn’t go bad, tastes like the fresh product, is free of chemical preservatives and doesn’t need expensive refrigerated transport or storage. Now, think of how many bottom lines of companies around the world such a technology could affect. Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) and its patented Ultra Shear Technology (“UST”) will be used to develop an innovative manufacturing technology in a new, federally-funded research program focused on food preservation and safety at Ohio State University’s College of Food, Agricultural and Environmental Sciences (“CFAES”).

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.60, up 4.96%, on 2,601 volume with 7 trades. The average volume for the last 60 days is 1,234 and the stock's 52-week low/high is $0.70/$6.05.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company, announced Enertec Corporation, the Israel-based defense solutions group of DPW subsidiary Coolisys Technologies, Inc., was awarded a $4.3 million second-stage contract award from an Israeli defense and aerospace contractor to supply computer-based command and control missile defense systems.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.5243, up 2.72%, on 1,424,393 volume with 2,248 trades. The average volume for the last 60 days is 2,130,769 and the stock's 52-week low/high is $0.4911/$5.95.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (SNOVF).

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) (the "Company" or "Koios"), is pleased to announce that the first flavour of its new and improved line of functional cognitive enhancing beverages, Pear Guava, is now available for purchase. Customers in both Canada and the United States can order the drink online from the company's website https://www.mentaltitan.com/product/pear-guava/  It is also available for purchase through Koios's large distribution network, which includes retailers such as SportLife Distribution, Max Muscle, and soon-to-be available through Amazon online.

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (SNOVF), closed the day's trading session at $0.1511, up 3.00%, on 12,865 volume with 6 trades. The average volume for the last 60 days is 63,670 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC:NUGL) (the “Company”), the cannabis industry's new standard of technology, today announces the eagerly anticipated launch of its brand locator and profile claiming features for the cannabis community and its rapidly growing fan base.

NUGL Inc. (OTC: NUGL), is a search engine and online directory for the marijuana industry. NUGL’s database includes listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands. The company focuses on leading the evolution in business relations, development and organic data in the cannabis industry with metasearch technology.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.54, up 0.98%, on 240,731 volume with 236 trades. The average volume for the last 60 days is 112,566 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Global financial services, technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) continues increasing profitability with a strong track record that includes processing transactions in over 50 countries and coming “close to the $3 billion mark” with over 154 million transactions, Net Element CEO Oleg Firer stated in an exclusive interview with NetworkNewsAudio (http://ccw.fm/Ty9Tr).

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.67, even for the day, on 44,605 volume with 306 trades. The average volume for the last 60 days is 142,155 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Virtual Crypto Technologies Inc. (OTCQB:VRCP), a client of NNW and technology company dedicated to making cryptocurrencies accessible to the public, specifically by creating payment solutions for businesses and consumers which combine Application Programming Interfaces and Mobile Applications for implementation across ATMs, PCs, tablets and other mobile devices. To view the full publication, titled “Acid Test for Cryptos and Blockchain Tech Increasingly about ‘Spendability’ and Usability,” visit:  http://nnw.fm/4H6qg. Also today, CryptoCurrencyWire released a report on the company detailing how VRCP’s announcement that it is encouraged as regulatory sentiment in the United States seems to be moving in favor of cryptocurrencies. To view the full press release, visit: http://ccw.fm/fW33d.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.12, even for the day, on 30,091 volume with 15 trades. The average volume for the last 60 days is 34,441 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

At the request of Investment Industry Regulatory Organization of Canada (“IIROC”), Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF) (“Sunniva” or the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent change in market activity. Also today, CannabisNewsWire released a report on the company detailing how SNNVF, through several wholly-owned subsidiaries, has operations in cannabis grow facilities, cannabis extraction facilities, medical cannabis clinics and the cannabis white label business. To view the full article, visit: http://cnw.fm/s1yOy.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $4.4068, off by 1.19%, on 138,841 volume with 330 trades. The average volume for the last 60 days is 39,434 and the stock's 52-week low/high is $4.43/$16.00.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; Frankfurt: A2DYWC), a company focused on the development and implementation of proprietary technologies for the energy industry, wishes to comment on a front-page article published by a local Vernal news publication. Also today, NetworkNewsWire released a report on the company detailing how PQEFF is partnering with a leading fluids processing company to test ways of improving oil yields in Petroteq’s oil sands extraction process. Cavitation Technologies, Inc. (OTCQB: CVAT) (“CTi”), which develops technologies used in various industries, is to work with Petroteq to analyze the efficiency of its workflow processes and ultimately decrease production costs, according to a Petroteq news release (http://nnw.fm/tGh6P).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.92, even for the day, on 347,575 volume with 246 trades. The average volume for the last 60 days is 208,492 and the stock's 52-week low/high is $0.28/$1.8892.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce it has appointed 20-year IBM veteran Mr. Geoff Riggs as Chief Information Officer.  Mr. Riggs will set the Company’s direction on information technology, e-commerce and artificial intelligence strategies to support TGOD’s domestic and global expansion.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $5.48, off by 3.86%, on 623,700 volume. The stock's 52-week low/high is $3.50/$8.28.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America Inc. (OTC:MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name “hempSMART™”, an affiliate marketing program to promote and sell its products, as well as leasing of real property and expansion of business into ancillary areas of the legalized cannabis and hemp industry. To view the full publication, titled “Proposed Legal Changes Offer a Boost for Cannabidiol Companies in the United States,” visit: http://cnw.fm/hW1EQ.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.02951, off by 2.93%, on 4,948,138 volume with 304 trades. The average volume for the last 60 days is 7,898,271 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.